These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 31400805

  • 1. Differences between primary central nervous system lymphoma and glioblastoma: topographic analysis using voxel-based morphometry.
    Yamashita K, Hiwatashi A, Togao O, Kikuchi K, Momosaka D, Hata N, Akagi Y, Suzuki SO, Iwaki T, Iihara K, Honda H.
    Clin Radiol; 2019 Oct; 74(10):816.e1-816.e8. PubMed ID: 31400805
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Primary central nervous system lymphoma and glioblastoma differentiation based on conventional magnetic resonance imaging by high-throughput SIFT features.
    Chen Y, Li Z, Wu G, Yu J, Wang Y, Lv X, Ju X, Chen Z.
    Int J Neurosci; 2018 Jul; 128(7):608-618. PubMed ID: 29183170
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. MRI as a diagnostic biomarker for differentiating primary central nervous system lymphoma from glioblastoma: A systematic review and meta-analysis.
    Suh CH, Kim HS, Jung SC, Park JE, Choi CG, Kim SJ.
    J Magn Reson Imaging; 2019 Aug; 50(2):560-572. PubMed ID: 30637843
    [Abstract] [Full Text] [Related]

  • 10. Multiparametric imaging-based differentiation of lymphoma and glioblastoma: using T1-perfusion, diffusion, and susceptibility-weighted MRI.
    Saini J, Kumar Gupta P, Awasthi A, Pandey CM, Singh A, Patir R, Ahlawat S, Sadashiva N, Mahadevan A, Kumar Gupta R.
    Clin Radiol; 2018 Nov; 73(11):986.e7-986.e15. PubMed ID: 30197047
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Permeability measurement using dynamic susceptibility contrast magnetic resonance imaging enhances differential diagnosis of primary central nervous system lymphoma from glioblastoma.
    Lee JY, Bjørnerud A, Park JE, Lee BE, Kim JH, Kim HS.
    Eur Radiol; 2019 Oct; 29(10):5539-5548. PubMed ID: 30877463
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Quantitative Evaluation of Diffusion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Differentiation Between Primary Central Nervous System Lymphoma and Glioblastoma.
    Lu S, Wang S, Gao Q, Zhou M, Li Y, Cao P, Hong X, Shi H.
    J Comput Assist Tomogr; 2017 Oct; 41(6):898-903. PubMed ID: 28806317
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Differentiating between Glioblastoma and Primary CNS Lymphoma Using Combined Whole-tumor Histogram Analysis of the Normalized Cerebral Blood Volume and the Apparent Diffusion Coefficient.
    Bao S, Watanabe Y, Takahashi H, Tanaka H, Arisawa A, Matsuo C, Wu R, Fujimoto Y, Tomiyama N.
    Magn Reson Med Sci; 2019 Jan 10; 18(1):53-61. PubMed ID: 29848919
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Machine learning applications for the differentiation of primary central nervous system lymphoma from glioblastoma on imaging: a systematic review and meta-analysis.
    Nguyen AV, Blears EE, Ross E, Lall RR, Ortega-Barnett J.
    Neurosurg Focus; 2018 Nov 01; 45(5):E5. PubMed ID: 30453459
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.